Our Champions of Decentralized Clinical Trials: Highlighting Our Remote Site Network Physicians
Innovators in Patient-Centered Research Across the Nation
In the evolving landscape of clinical research, decentralized clinical trials (DCTs) are transform clinical trials—enabling more flexible, accessible, and patient-centered experiences. In doing our part to support DCTs, we formed our Remote Site Network, a diverse group of physicians who connect cutting-edge research and real-world patient care. Their commitment and expertise ensure that clinical trials are delivered wherever patients reside, going beyond traditional site models and expanding access to new treatments.
Decentralized clinical trials empower patients to participate from their homes or local communities, reducing the need for frequent travel and minimizing interruptions to daily lives. Our Remote Site Network embodies this vision, assembling highly skilled physicians across specialties and geographies. These leaders drive research participation, deliver compassionate care, and pioneer new medical frontiers.
Let’s meet the physicians propelling our mission forward—each bringing a unique combination of skills, experience, and passion for advancing patient outcomes.
Dr. Mohammed Ishaqe Memon
Dr. Mohammed Ishaqe Memon stands out as a board-certified expert in medical oncology, hematology, and internal medicine. With over 30 years of experience, Dr. Memon has made transformative impacts on cancer care, clinical leadership, and research. Licensed to practice in Illinois, Iowa, and Mississippi, he joined our Remote Site Network in 2023, where he continues to advance oncology through both hands-on care and innovative research.
Dr. Memon currently participates in two ongoing DCTs, including a pre-screening study within oncology and a long-term follow-up study for patients undergoing specific lung cancer treatments. His dedication to improving patient outcomes through decentralized trials exemplifies the power of bringing research directly to patients.
Dr. Richard Ruh
One of Circuit’s longest-standing champions, Dr. Richard Ruh, holds deep expertise in family medicine and healthcare leadership. Licensed in New York, Dr. Ruh has completed over fourteen clinical trials and currently leads seven ongoing studies. Since 1993, he has served as President and Managing Partner of Orchard Park Family Practice, P.C., providing comprehensive care to his community in western New York.
His research portfolio is extensive, spanning respiratory and allergic conditions, osteoarthritis, gastroesophageal reflux disease, and dermatological issues. As both a practitioner and principal investigator, Dr. Ruh’s commitment to advancing patient care remains unwavering.
Dr. Lubna Hasanain
Dr. Lubna Hasanain is a seasoned pediatrician and public health leader, joining our Remote Site Network in April 2024. With over 30 years of experience, she holds medical licenses in 41 states. She has served in key governance and educational roles, including President of the Alameda-Contra Costa Medical Association and Pediatric Clerkship Director for Drexel-Permanente.
Dr. Hasanain’s work in clinical care, advocacy, and curriculum development for future healthcare leaders is matched by her dedication to decentralized trials, ensuring pediatric research reaches more families nationwide.
Dr. Ashok Subramanian
Board-certified in emergency medicine, Dr. Ashok Subramanian is licensed in 38 states, greatly expanding our reach. With over two decades of clinical and research experience, Dr. Subramanian brings expertise in molecular medicine and genetics to DCTs. He is an attending physician at major healthcare systems and co-founder of CarePortMD, a telehealth platform that advances coordinated care.
Dr. Subramanian’s current research includes a DCT identifying patients for a randomized controlled trial for type 1 diabetes, and prior involvement in an observational trial on tobacco exposure. His work in policy, innovation, and patient engagement underscores the importance of decentralized trials in emergency medicine.
Dr. Lindsay Van Pelt
Dr. Lindsay Van Pelt is a board-certified emergency medicine physician and clinical research leader, specializing in CNS and neurology studies. Licensed in 16 states, Dr. Van Pelt has led multiphase trials across neurology, endocrinology, immunology, and more. Her expertise in pharmacovigilance, regulatory compliance, and patient safety ensures that decentralized trials meet the highest standards.
Currently, Dr. Van Pelt is initiating an interventional study for patients experiencing seizures. Her passion for innovative research and dedication to patient care continue to shape the future of clinical development.
Dr. Frederick Nahm
Triple board-certified in neurology, clinical neurophysiology, and electrodiagnostic medicine, Dr. Frederick Nahm brings 18 years of experience across ambulatory, institutional, and corporate settings. Licensed in 48 states and the District of Columbia, Dr. Nahm is the founder of NeuroCare Health P.C. and has led initiatives in virtual care and remote neurological monitoring.
His research includes decentralized phase 3 and phase 1b studies for treatments for essential tremor, lupus, and dementia, demonstrating his commitment to expanding access to neurological research nationwide.
Leaders Licensed Nationwide: The “51-ers”
Flexibility and inclusion are hallmarks of decentralized clinical trials—and our “51-ers,” physicians licensed in all 50 states plus the District of Columbia, embody this mission fully. These principal investigators deliver research and care nationwide, making clinical studies accessible to every patient.
Dr. Martin Maimon
Board-certified in internal medicine and pediatrics, Dr. Martin Maimon’s career spans telehealth, clinical leadership, and public health. He has held key roles at Amazon Care and 98point6, and founded Community Health Promotion LLC, which focuses on personalized, patient-centered care.
Dr. Maimon’s contributions include mentoring fellow investigators and supporting phase 3 randomized DCTs for essential tremor. His work in telemedicine and academic leadership positions him as a driving force behind nationwide decentralized trials.
Dr. Jerri Jensen
Dr. Jerri Jensen is a board-certified family physician with over thirty years of experience in family medicine, urgent care, and telehealth. Licensed in all 50 states and D.C., Dr. Jensen blends conventional medicine with integrative therapies and has served in medical director roles across multiple platforms.
Her advocacy for wellness and education, combined with participation in new interventional studies for seizure treatments, reflects her holistic approach to patient-centered research.
Dr. Lianne Marks
With board certification in internal medicine and licensure in all 50 states, Dr. Lianne Marks brings deep clinical and academic experience to our Remote Site Network. An Associate Adjunct Professor at Texas A&M College of Medicine, Dr. Marks has held pivotal roles in research operations and medical education, ensuring rigor and compassion in decentralized trials delivery.
Her participation in interventional studies for essential tremor and diabetes referral registries showcases her commitment to expanding trial access and improving outcomes for diverse patient populations.
Why Decentralized Trials Matter: A Patient-First Approach
The physicians of our Remote Site Network are not only clinical experts—they are innovators and advocates for a patient-first model of research. Decentralized clinical trials offer numerous benefits:
• Improved Access: Patients can participate regardless of location or mobility, breaking geographic barriers.
• Convenience: Home-based participation reduces travel, time, and disruption to daily life.
• Increased Inclusion: Multi-state licensing ensures inclusion of varied populations, leading to more representative and robust research outcomes.
• Quality: Rigorous standards and physician oversight maintain research integrity and patient safety.
• Innovation: Physicians leverage telehealth, virtual monitoring, and cutting-edge methodologies to advance medicine.
Looking Ahead
The dedicated physicians of our Remote Site Network, and our broader Community Research Network, are redefining clinical trials—making research more accessible, efficient, and meaningful for patients everywhere. Their collective expertise across various therapeutic areas ensures that decentralized trials can reach families, communities, and individuals who need them most.
As clinical research continues to evolve, these physician champions will remain at the forefront, shaping the future of medicine and patient care—one trial at a time.